Glycemic targets for the optimal treatment of GDM

Clinical Obstetrics and Gynecology

Volumn 56, Issue 4, 2013, Pages 788-802

  Langer, Oded ^a  

^a NONE

Author keywords

Diabetes in pregnancy; Levels of glycemia; Perinatal outcome

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CONGENITAL MALFORMATION; DIET; DIET THERAPY; EXERCISE; FETUS GROWTH; FETUS LUNG MATURATION; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERINSULINEMIA; HYPERTROPHY; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN TREATMENT; LARGE FOR GESTATIONAL AGE; MACROSOMIA; NEWBORN DEATH; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREVALENCE; RESPIRATORY DISTRESS SYNDROME; SPONTANEOUS ABORTION; WEIGHT GAIN;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES, GESTATIONAL; DRUG MONITORING; FEMALE; FETAL GROWTH RETARDATION; FETAL MACROSOMIA; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; PREGNANCY; PREGNANCY OUTCOME;

EID: 84887828324     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3182a8e07d     Document Type: Article

References (92)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329: 977-986.
2. Stratton IM, Adler AL, Neil HA, et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000;321:405-412.
3. Langer O, Rodriguez DA, Xenakis EMJ, et al. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol. 1994;170:1036-1047.
4. Langer O. Is normoglycemia the correct threshold to prevent complications in the pregnant diabetic patient?. Diabetes Review. 1996;4:2-10.
5. Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med. 2000;9:35-41.
6. Langer O. A spectrum of glucose thresholds may effectively prevent complications in the pregnant diabetic patient. Semin Perinatol. 2002;26: 196-205.
7. Langer O. The Diabetes in Pregnancy Dilemma. Lanham, MA: University Press of America.
8. Feinstein AR. Clinical Epidemiology. Philadelphia, PA: Saunders; 609-610.
9. Yogev Y, Langer O, Chen R, et al. Diurnal glycemic profile in obese and normal weight non-diabetic pregnant women. Am J Obstet Gynecol. 2004;191:949-953.
10. Executive summary. Standards of medical care in diabetes. Diabetes Care. 2011;34:S4-S10.
11. Clinical management guidelines for obstetriciangynecologists. ACOG Practice Bulletin. 2001; 1-14.
12. Landon MR, Gabbe SG. Gestational diabetes mellitus. Obstet Gynecol. 2011;118:1379-1393.
13. Mazze R, Yogev Y, Langer O. Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy. J Matern Fetal Neonatal Med. 2012;7:1171-1175.
14. Siegelaar SE, Holleman F, Hoekstra JBL, et al. Glucose variability: Does it matter?. Endocr Rev. 2010;31:171-182.
15. Kerssen A, de Valk HW, Visser GHA. Day-today glucose variability during pregnancy in women with type 1 diabetes mellitus: Glucose profiles measured with the continuous glucose monitoring system. BJOG. 2004;111: 919-924.
16. Murphy HR, Rayman G, Duffield K, et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care. 2007;30:2785-2790.
17. Secher AL, Ringholm L, Andersen HU, et al. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: A randomized controlled trial. Diabetes Care. 2013;36:1877-1883.
18. Evers IM, deValk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ. 2004;328:915.
19. Kerssen A, Evers IM, de Valk, et al. Poor glucose control in women with type 1 diabetes mellitus and ''safe'' hemoglobin A1c values in the first trimester of pregnancy. J Matern Fetal Neonatal Med. 2003;13:309-313.
20. Kerssen A, deValk HW, Visser GH. Do HbA1c levels and the self-monitoring of blood glucose levels adequately reflect glycemic control during pregnancy in women with type 1 diabetes mellitus?. Diabetologia. 2006;49:25-28.
21. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
22. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005; 54:1615-1625.
23. Brustman L, Langer O, Engel S. Verified selfmonitored blood glucose data versus glycosylated hemoglobin and glycosylated serum protein as a means of predicting short and long-term metabolic control in gestational diabetes. Am J Obstet Gynecol. 1987;157:699-703.
24. Lowe LP, Metzger BE, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcome (HAPO) study. Diabetes Care. 2012;35:574-580.
25. Landon MB, Spoong CY, Thorn E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361:1339-1348.
26. Landon MB. Is there a benefit to the treatment of mild gestational diabetes mellitus?. Am J Obstet Gynecol. 2010;649-653.
27. Crowther CA, Hiller JE, Moses JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352: 2477-2486.
28. Langer O, Yogev Y, Most O, et al. Gestational diabetes: The consequences of not treating. Am J Obstet Gynecol. 2005;192:989-997.
29. Langer O, Yogev Y, Xenakis E, et al. Overweight and obese in gestational diabetes: The impact on pregnancy outcome. Am J Obstet Gyn. 2005;192: 1768-1776.
30. Langer-Most O, Langer O. Gestational diabetes: Maternal weight gain in relation to fetal growth, treatment modality, BMI and glycemic control. J Matern Fetal Medicine. 2012;25:2458-2463.
31. Chengi YW, Chung JH, Kurbisch-Block I, et al. Gestational weight gain and gestational diabetes mellitus: Perinatal outcomes. Obstet Gynecol. 2008;112:1015-1022.
32. Artal R, Lockwood CJ, Brown HL. Weight gain recommendations in pregnancy and the obesity epidemic. Obstet Gynecol. 2010;115:152-155.
33. Bergman RN, Findgood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985;6:45-86.
34. Berkus M, Langer O, McFarland M, et al. Effects of treatment on glucose metabolism during pregnancy. Am J Obstet Gynecol. 1998;178: S58. Abstract.
35. Langer O. Management of gestational diabetes. Clinical Obstet and Gyn. 2000;43:106-115.
36. TamCS, XieW, JohnsonWD, et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care. 2012;35:1605-1610.
37. Freinkel N. American Diabetes Association workshop-conference on gestational diabetes. Diabetes Care. 1980;3:399-401.
38. Freinkel N. Proceedings of the Second International Workshop-Conference on Gestational Diabetes Mellitus, Vol. 34 (Diabetes, Suppl 2). 1985;34 (Diabetes Suppl):1-130.
39. Management of diabetes mellitus in pregnancy. ACOG Tech Bull. 1986;92:1-5.
40. ACOG Practice Bulletin clinical management guidelines for obstetrician-gynecologists number 30. 2001:1-13.
41. McFarland MB, Langer O, Conway DL, et al. Dietary therapy for gestational diabetes: How long is long enough?. Obstet Gynecol. 1999;93: 978-982.
42. Langer O, Berkus M, Brustman L, et al. The rationale for insulin management in gestational diabetes mellitus. Diabetes. 1991;40(S2):186-190.
43. Metzger B, Coustan D. International Workshop on Gestational Diabetes. Diabetes Care. 1998;21 (Suppl 2):B161-167.
44. Langer O. Maternal glycemic criteria for insulin therapy in GDM. Diabetes Care. 1998;21: B1-B8.
45. American College of Obstetricians and Gynecologists. Management of diabetes mellitus in pregnancy. Technical Bulletin
46. Washington, DC: ACOG. 46. Yogev Y, Langer O. Pregnancy outcome in obese and morbidly obese gestational diabetic women. Eur J Obstet Gynecol Reprod Biol. 2007;21-26.
47. Langer O. Type 2 diabetes in pregnancy: Exposing deceptive appearances. J Matern Fetal Neonatal Med. 2008;21:181-189.
48. Karlsson K, Kjellmer I. The outcome of diabetic pregnancies in relation to the mother's blood sugar level. Am J Obstet Gynecol. 1972;112: 213-220.
49. Pettitt DJ, Knowles WC, Baird HR, et al. Gestational diabetes: Infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care. 1980;3:458-464.
50. Mondestin MA, Ananth CV, Smulian JC, et al. Birth weight and fetal death in the United States: The effect of maternal diabetes during pregnancy. Am J Obstet Gynecol. 2002;187:922-926.
51. O'Sullivan JB, Charoes D, Mahan CM, et al. Gestational diabetes and perinatal mortality rate. Am J Obstet Gynecol. 1973;1:901-904.
52. Schmidt MI, Duncan BB, Reichelt AJ, et al. Gestational diabetes mellitus diagnosed with 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care. 2001;24: 1151-1153.
53. Miodovnik M, Lavin JP, Knowles HC, et al. Spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol. 1984;150: 372-376.
54. Wright AD, Nicholson HO, Pollock A, et al. Spontaneous abortion and diabetes mellitus. Postgrad Med J. 1983;59:295-298.
55. Miodovnik M, Mimouni F, Tsang RC, et al. Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulindependent diabetic women. Am J Obstet Gynecol. 1985;153:439-442.
56. Miodovnik M, Mimouni F, Tsand RC, et al. Glycemic control and spontaneous abortion in insulin-dependent diabetic women. Obstet Gynecol. 1986;68:366-369.
57. Greene MF, Hare JW, Cloherty JP, et al. Firsttrimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology. 1989;39:225-231.
58. Rosenn B, Miodovnik M, Combs CA, et al. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol. 1994;84: 515-520.
59. Fuhrman K, Reiher H, Semmler K, et al. Prevention of congenital malformation sin infants of insulin-dependent diabetic mothers. Diabetes Care. 1983;6:219-224.
60. Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception care of diabetes: Glycemic control prevents congenital anomalies. JAMA. 1991;265: 731-736.
61. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981;304:1331-1334.
62. Mills JL, Knopp RH, Simpson JL, et al. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med. 1988;318:671-676.
63. Schaefer-Graf U, Buchanan TA, Xiang A, et al. Patterns of congenital anomalies and relationship to initial maternal fasting levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol. 2000;182:313-320.
64. Jacobson JD, Cousins L. A population-based study of maternal and perinatal outcome in patients with gestational diabetes. Am J Obstet Gynecol. 1989;161:981-986.
65. Berggren EK, Mele L, Landon MB, et al. Perinatal outcomes in Hispanic and non-Hispanic white women with mild gestational diabetes. Obstet Gynecol. 2012;120:1099-1104.
66. Chengi YW, Chung JH, Block-Kurbisch I, et al. Treatment of gestational diabetes mellitus: Glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J Matern Fetal Neonatal Med. 2012;25:379-384.
67. O'Sullivan EP, Avalos G, O'Reilly M, et al. The prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia. 2011;54:1670-1675.
68. Crowther CA, Hague WM, Middleton PE, et al. The IDEAL study: Investigation of dietary advice and lifestyle for women with borderline gestational diabetes: A randomized controlled trial -study protocol. BMC Pregnancy Childbirth. 2012;12:106.
69. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Maternal postprandial glucose levels and infant birth weight: The diabetes in early pregnancy study. Am J Obstet Gynecol. 1991;164: 103-111.
70. William SP, Leveno KJ, Guzick DS, et al. Glucose threshold for macrosomia in pregnancy complicated by diabetes. Am J Obstet Gynecol. 1986;154: 470-475.
71. Drexel H, Bichler A, Sailer S, et al. Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus. Diabetes Care. 1988;11:761-768.
72. Roversi GD, Garguilo M, Nicolini U, et al. Maximal tolerated insulin therapy in gestational diabetes. Diabetes Care. 1980;3:479-484.
73. Jovanovic-Peterson L, Durak EP, Peterson CM. Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Clin J Obstet Gynecol. 1989;161: 415-419.
74. Landon MB, Gabbe SG, Piana R, et al. Neonatal morbidity in pregnancy complicated by diabetes mellitus: Predictive value of maternal glycemic profiles. Am J Obstet Gynecol. 1987;156: 1089-1095.
75. Langer O, Mazze R. The relationship between large-for-gestational age infants and glycemic control in women with gestational diabetes. Am J Obstet Gynecol. 1988;159:1478-1483.
76. Langer O, Levy J, Brustman L, et al. Glycemic control in gestational diabetes mellitus - how tight is tight enough: Small for gestational age versus large for gestational age?. Am J Obstet Gynecol. 1989;161:646-653.
77. Adamkin DH. Committee on fetus and newborn. Pediatrics. 2011;127:575-579.
78. Robert MF, Neff RK, Hubbell JP, et al. Association between maternal diabetes and the respiratory distress syndrome. N Engl J Med. 1976;294: 357-360.
79. Moore T. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol. 2002;186: 641-650.
80. Ojomo EO, Coustan DR. Absence of evidence of pulmonary maturity at amniocentesis in term infants of diabetic mothers. Am J Obstet Gynecol. 1990;163:954-957.
81. Piper JM, Langer O. Does maternal diabetes delay fetal pulmonary maturity?. Am J Obstet Gynecol. 1993;168:783-786.
82. Berkowitz K, Reyes C, Saadat P, et al. Fetal lung maturation: Comparison of biochemical indices in gestational diabetic and nondiabetic pregnancies. J Reprod Med. 1997;47:793-800.
83. Piper JM, Langer O. Is lung maturation related to fetal growth in diabetic or hypertensive pregnancies?. Eur J Obstet Gynecol Reprod Biol. 1993;51: 15-19.
84. Piper JM, Xenakis EMJ, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies. J Matern-Fetal Med. 1998;7: 148-153.
85. Suhonen L, Teramo K. Hypertension and preeclampsia in women with gestational glucose intolerance. Acta Obstet Gynecol Scand. 1993;72:269-272.
86. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.
87. Joffe GM, Esterlitz JR, Levine RJ, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1998;179:1032-1037.
88. Innes KE, Wimsatt JH, McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol. 2001;97:905-910.
89. Levin G, Kestenbaum B, Chen I, et al. Glucose, insulin, and incident hypertension in the multiethnic study of atherosclerosis. Am J Epidemiol. 2010;172:1144-1154.
90. Xun P, Liu K, Cao W, et al. Fasting insulin level is positively associated with incidence of hypertension among American young adults. Diabetes Care. 2012;35:1532-1537.
91. Bauman WA, Maimen M, Langer O. An association between hyperinsulinemia and hypertension during the third trimester of pregnancy. Am J Obstet Gynecol. 1988;159:446-450.
92. Yogev Y, Xenakis EMJ, Langer O. The association between preeclampsia and the severity of gestational diabetes: The impact of glycemic control. Am J Obstet Gynecol. 2004;191:1655-1660.